Evidence map›Paper›PMID 40465016›Full record

ReviewWorld journal of microbiology & biotechnology2025

The cardamom-Fusarium pathosystem: current knowledge and future directions.

Sandra Tomichen, Shweta Panchal

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sandra TomichenSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Shweta PanchalSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India. shwetapanchal84@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small cardamom (Elettaria cardamomum), known as the "Queen of Spices," is severely affected by rot diseases caused by Fusarium oxysporum Schlecht, leading to significant crop losses globally. This review provides an overview about the plant, its pathogen F. oxysporum and the biocontrol agents used. The pathogenesis of the fungus, the host defence mechanisms and the mechanisms used by biocontrol agents like Bacillus subtilis, Pseudomonas fluorescens, Trichoderma viride, Trichoderma harzianum, and Arbuscular Mycorrhizal Fungi (AMF) are discussed. F. oxysporum is a globally recognized pathogen responsible for wilting diseases in a wide range of economically important plants, including tomato, watermelon, asparagus, potato, banana, cucumber, pepper, chickpea, cotton, and more. Additionally, it is known to cause rot disease in cardamom. This review also recognizes the lacunae in plant pathology research in this pathosystem and highlights future research approaches that are needed to improve our understanding of cardamom-Fusarium biology and to find effective biocontrols. At this point, it is imperative to support studies that examine the physiological and genetic responses of the organisms involved as well as extensive omic research to create a model of the interactions between cardamom, Fusarium, and the biocontrol agent. Development of specific techniques for microscopic visualization of the interactions and in vitro growth of cardamom seedlings will accelerate this research. These strategies hold potential for mitigating the devastating impact of F. oxysporum on cardamom cultivation.

Indexed as

ElettariaFusariumPlant DiseasesBiological Control AgentsHost-Pathogen InteractionsMycorrhizaeBiological Control AgentsBiocontrolCardamomFusarium oxysporumFusarium rot and wilt

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.